机构地区:[1]湖北中医药大学附属医院肝病研究所,湖北武汉430061 [2]湖北中医药大学
出 处:《中西医结合肝病杂志》2013年第2期90-92,共3页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基 金:国家自然科学基金资助项目(No.90709041;30672590;30271562;30371787;81102531;81274147);国家科技部重大基础研究项目(No."973"项目;2002CCC00300);湖北省自然科学基金重点项目(No.2011CDB463);武汉市科技厅重大项目(No.201260523199)
摘 要:目的:研究地五养肝胶囊对肝肾精虚/MSG-肝再生-大鼠肝再生的影响。方法:复制肝肾精虚/MSG-肝再生-大鼠模型(简称"模型组")和正常大鼠肝大部分切除再生模型(简称"PHx组")。将实验大鼠分4组:模型组、PHx组、对照组和治疗组,每组32只。治疗组大鼠以地五养肝胶囊灌胃,除PHx组外另两组大鼠以等体积生理盐水灌胃。在术后1、3、7、10天时分别观察大鼠的肝再生度、肝再生指数(%)和肝细胞分裂指数MI。结果:模型组大鼠术后第1天肝再生度、肝再生指数、MI分别为(0.34±0.10)、(1.88±0.14)、(1.05±0.12)均显著高于PHx组(0.22±0.08)、(1.46±0.13)、(0.86±0.16)和对照组(0.21±0.05)、(1.47±0.18)、(0.87±0.16),P均<0.05;模型组大鼠术后第3、7和10天肝再生度、肝再生指数、MI分别为(0.42±0.08、0.57±0.12、0.70±0.08),(2.07±0.04、2.41±0.06、2.84±0.10)和(1.04±0.18、0.41±0.16、0.15±0.03),均显著低于PHx组(0.53±0.10、0.73±0.09、0.88±0.06),(2.31±0.29、3.02±0.30、3.49±0.05),(1.85±0.19、0.62±0.03、0.29±0.04)和对照组(0.54±0.09、0.71±0.11、0.90±0.10),(2.33±0.42、3.07±0.13、3.46±0.05),(1.81±0.04、0.67±0.18、0.28±0.05),P均<0.05。治疗组大鼠术后第1天肝再生度、肝再生指数、MI分别为(0.13±0.07)、(1.52±0.11)、(0.77±0.14)均显著低于模型组大鼠(0.34±0.10)、(1.88±0.14)、(1.05±0.12),P均<0.05;治疗组大鼠术后3、7、10天肝再生度、肝再生指数、MI分别为(0.50±0.05、0.74±0.06、0.86±0.03),(2.19±0.11、2.84±0.12、3.27±0.06),(1.89±0.13、0.57±0.20、0.28±0.04)均显著高于模型组(0.42±0.08、0.57±0.12、0.70±0.08),(2.07±0.04、2.41±0.06、2.84±0.10),(1.04±0.18、0.41±0.16、0.15±0.03),P均<0.05。结论:地五养肝胶囊可一定程度地纠正肝肾精虚/MSG-肝再生-大鼠的肝再生紊乱,早期可抑制肝再生的异常亢进,中晚期可一定程度地改善被抑制的肝再生,使损伤的肝组织得以再生修复。通过下丘脑-垂�Objective:To research the influence of Diwuyanggan capsule on liver regeneration of essence deficiency of liver and kidney/MSG-liver regeneration-rat. Methods: Reproduction with the essence deficiency of liver and kidney/MSG-liver regeneration-rat model referred to as "model group", reproduction with the two-thirds partial hepatectomy for liver regeneration model referred to as the "PHx group" . Experimental rats were randomly divided into model group, PHx group , saline control group and treatment group. The treatment group was given Diwuyanggan capsule by gastra garage, the control group was given same volume normal saline by gstrogavage. Postoperative continued administration. Analysis of liver regeneration degree of liver regeneration index and liver mitotic index MI changes. Results: At the first postoperative day, liver regeneration degree (0.34 ±0.10), liver regeneration index (1.88±0. 14) and liver mitotic index MI (1.05±0.12) of the model group were significantly higher than the PHx group (liver regeneration degree 0.22 ±0.08, liver regeneration index 1.46±0.13, MI 0.86±0.16) and saline control group ( liver regeneration degree 0.21±0.05, liver regeneration index 1.47±0.18, MI 0.87±0.16), P〈0.05. At Postoperative 3, 7 and 10 days, the liver regeneration degree (0.42±0.08, 0.57±0.12, 0.70±0.08), liver re- generation index (2. 07±0.04, 2.41±0.06, 2.84±0.10) and MI (1.04±0.18, 0.41±0.16, 0.15 ± 0.03) of model group were significantly lower than in PHx group (liver regeneration degree 0.53 + 0.10, 0.73 ± 0.09, 0.88±0.06, liver re- generation index 2.31±0.29, 3.02 ± 0.30, 3.49 ± 0.05, MI 1.85± 0.19, 0.62±0. 03, 0.29±0.04) and saline control group (liver regeneration degree 0.54±0.09, 0.71±0. 11, 0.90±0.10, liver regeneration index 2.33±0.42, 3.07±0.13, 3.46±0.05, MI 1.81±0.04, 0.67±0.18, 0.28±0.05), P〈0.05. After the treatment of Diwuyanggan capsule, the first day of liver regeneration degree (0.13±0.07), liver
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...